Using dental pulp stem cells for stroke therapy

Maria R. Gancheva, Karlea L. Kremer, Stan Gronthos, Simon Koblar

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Stroke is a leading cause of permanent disability world-wide, but aside from rehabilitation, there is currently no clinically-proven pharmaceutical or biological agent to improve neurological disability. Cell-based therapies using stem cells, such as dental pulp stem cells, are a promising alternative for treatment of neurological diseases, including stroke. The ischaemic environment in stroke affects multiple cell populations, thus stem cells, which act through cellular and molecular mechanisms, are promising candidates. The most common stem cell population studied in the neurological setting has been mesenchymal stem cells due to their accessibility. However, it is believed that neural stem cells, the resident stem cell of the adult brain, would be most appropriate for brain repair. Using reprogramming strategies, alternative sources of neural stem and progenitor cells have been explored. We postulate that a cell of closer origin to the neural lineage would be a promising candidate for reprogramming and modification towards a neural stem or progenitor cell. One such candidate population is dental pulp stem cells, which reside in the root canal of teeth. This review will focus on the neural potential of dental pulp stem cells and their investigations in the stroke setting to date, and include an overview on the use of different sources of neural stem cells in preclinical studies and clinical trials of stroke.

LanguageEnglish
Article number422
JournalFrontiers in Neurology
Volume10
Issue numberAPR
DOIs
Publication statusPublished - 1 Jan 2019

Keywords

  • Cell-based therapy
  • Dental pulp stem cells
  • Differentiation
  • Ischaemic stroke
  • Multipotent
  • Neural crest
  • Neural stem cells
  • Reprogramming

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Gancheva, M. R., Kremer, K. L., Gronthos, S., & Koblar, S. (2019). Using dental pulp stem cells for stroke therapy. Frontiers in Neurology, 10(APR), [422]. https://doi.org/10.3389/fneur.2019.00422
Gancheva, Maria R. ; Kremer, Karlea L. ; Gronthos, Stan ; Koblar, Simon. / Using dental pulp stem cells for stroke therapy. In: Frontiers in Neurology. 2019 ; Vol. 10, No. APR.
@article{944372dd61154b37a23f8ae5d70aeadf,
title = "Using dental pulp stem cells for stroke therapy",
abstract = "Stroke is a leading cause of permanent disability world-wide, but aside from rehabilitation, there is currently no clinically-proven pharmaceutical or biological agent to improve neurological disability. Cell-based therapies using stem cells, such as dental pulp stem cells, are a promising alternative for treatment of neurological diseases, including stroke. The ischaemic environment in stroke affects multiple cell populations, thus stem cells, which act through cellular and molecular mechanisms, are promising candidates. The most common stem cell population studied in the neurological setting has been mesenchymal stem cells due to their accessibility. However, it is believed that neural stem cells, the resident stem cell of the adult brain, would be most appropriate for brain repair. Using reprogramming strategies, alternative sources of neural stem and progenitor cells have been explored. We postulate that a cell of closer origin to the neural lineage would be a promising candidate for reprogramming and modification towards a neural stem or progenitor cell. One such candidate population is dental pulp stem cells, which reside in the root canal of teeth. This review will focus on the neural potential of dental pulp stem cells and their investigations in the stroke setting to date, and include an overview on the use of different sources of neural stem cells in preclinical studies and clinical trials of stroke.",
keywords = "Cell-based therapy, Dental pulp stem cells, Differentiation, Ischaemic stroke, Multipotent, Neural crest, Neural stem cells, Reprogramming",
author = "Gancheva, {Maria R.} and Kremer, {Karlea L.} and Stan Gronthos and Simon Koblar",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fneur.2019.00422",
language = "English",
volume = "10",
journal = "Frontiers in Neurology",
issn = "1664-2295",
publisher = "Frontiers Media S.A.",
number = "APR",

}

Gancheva, MR, Kremer, KL, Gronthos, S & Koblar, S 2019, 'Using dental pulp stem cells for stroke therapy', Frontiers in Neurology, vol. 10, no. APR, 422. https://doi.org/10.3389/fneur.2019.00422

Using dental pulp stem cells for stroke therapy. / Gancheva, Maria R.; Kremer, Karlea L.; Gronthos, Stan; Koblar, Simon.

In: Frontiers in Neurology, Vol. 10, No. APR, 422, 01.01.2019.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Using dental pulp stem cells for stroke therapy

AU - Gancheva, Maria R.

AU - Kremer, Karlea L.

AU - Gronthos, Stan

AU - Koblar, Simon

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Stroke is a leading cause of permanent disability world-wide, but aside from rehabilitation, there is currently no clinically-proven pharmaceutical or biological agent to improve neurological disability. Cell-based therapies using stem cells, such as dental pulp stem cells, are a promising alternative for treatment of neurological diseases, including stroke. The ischaemic environment in stroke affects multiple cell populations, thus stem cells, which act through cellular and molecular mechanisms, are promising candidates. The most common stem cell population studied in the neurological setting has been mesenchymal stem cells due to their accessibility. However, it is believed that neural stem cells, the resident stem cell of the adult brain, would be most appropriate for brain repair. Using reprogramming strategies, alternative sources of neural stem and progenitor cells have been explored. We postulate that a cell of closer origin to the neural lineage would be a promising candidate for reprogramming and modification towards a neural stem or progenitor cell. One such candidate population is dental pulp stem cells, which reside in the root canal of teeth. This review will focus on the neural potential of dental pulp stem cells and their investigations in the stroke setting to date, and include an overview on the use of different sources of neural stem cells in preclinical studies and clinical trials of stroke.

AB - Stroke is a leading cause of permanent disability world-wide, but aside from rehabilitation, there is currently no clinically-proven pharmaceutical or biological agent to improve neurological disability. Cell-based therapies using stem cells, such as dental pulp stem cells, are a promising alternative for treatment of neurological diseases, including stroke. The ischaemic environment in stroke affects multiple cell populations, thus stem cells, which act through cellular and molecular mechanisms, are promising candidates. The most common stem cell population studied in the neurological setting has been mesenchymal stem cells due to their accessibility. However, it is believed that neural stem cells, the resident stem cell of the adult brain, would be most appropriate for brain repair. Using reprogramming strategies, alternative sources of neural stem and progenitor cells have been explored. We postulate that a cell of closer origin to the neural lineage would be a promising candidate for reprogramming and modification towards a neural stem or progenitor cell. One such candidate population is dental pulp stem cells, which reside in the root canal of teeth. This review will focus on the neural potential of dental pulp stem cells and their investigations in the stroke setting to date, and include an overview on the use of different sources of neural stem cells in preclinical studies and clinical trials of stroke.

KW - Cell-based therapy

KW - Dental pulp stem cells

KW - Differentiation

KW - Ischaemic stroke

KW - Multipotent

KW - Neural crest

KW - Neural stem cells

KW - Reprogramming

UR - http://www.scopus.com/inward/record.url?scp=85067882404&partnerID=8YFLogxK

U2 - 10.3389/fneur.2019.00422

DO - 10.3389/fneur.2019.00422

M3 - Review article

VL - 10

JO - Frontiers in Neurology

T2 - Frontiers in Neurology

JF - Frontiers in Neurology

SN - 1664-2295

IS - APR

M1 - 422

ER -

Gancheva MR, Kremer KL, Gronthos S, Koblar S. Using dental pulp stem cells for stroke therapy. Frontiers in Neurology. 2019 Jan 1;10(APR). 422. https://doi.org/10.3389/fneur.2019.00422